Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 209,893 $ 190,765
Accounts receivable, net 291,659 221,412
Inventories 138,181 149,718
Prepaid expenses and other assets 498,808 448,209
Total current assets 1,138,541 1,010,104
Property and equipment, net 19,068,807 16,810,650
Goodwill 135,764 135,764
Trade names 500,525 500,525
Other long-term assets 1,697,764 1,512,768
Total assets 22,541,401 19,969,811
Current liabilities:    
Current portion of long-term debt 875,899 1,323,769
Accounts payable 169,655 171,106
Accrued expenses and other liabilities 1,206,430 1,180,026
Advance ticket sales 3,200,593 3,105,964
Total current liabilities 5,452,577 5,780,865
Long-term debt 13,730,277 11,776,721
Other long-term liabilities 1,148,659 986,786
Total liabilities 20,331,513 18,544,372
Commitments and contingencies (Note 13)
Shareholders' equity:    
Ordinary shares, $0.001 par value; 980,000,000 shares authorized; 455,257,489 shares issued and outstanding at December 31, 2025 and 439,861,281 shares issued and outstanding at December 31, 2024 455 440
Additional paid-in capital 8,227,432 7,921,918
Accumulated other comprehensive income (loss) (451,365) (507,039)
Accumulated deficit (5,566,634) (5,989,880)
Total shareholders' equity 2,209,888 1,425,439
Total liabilities and shareholders' equity $ 22,541,401 $ 19,969,811